Nature's Sunshine Cuts Full-Year Outlook After 9% Sales Drop, Profit Falls 64%
NATR is trading near its 52-week low of $11.92 (3.1% below the low).
Summary
Q3 net sales fell 9% to $116.6 million and GAAP net income dropped to $1.9 million, or $0.11 a diluted share, from $5.3 million, or $0.30, a year ago, while adjusted EPS came in at 14 cents. Adjusted EBITDA slid to $11.1 million from $15.2 million. The miss was concentrated in Asia, where sales fell 14.9% on China operational disruptions that CEO Ken Romanzi said hit the consultant leadership base harder than expected, plus continued investment in a Digital business coming off several strong quarters. Management cut full-year 2026 net sales guidance to $460-$470 million from $490-$500 million and adjusted EBITDA to $44-$48 million from $48-$52 million, citing a stronger dollar and China weakness. The stock sits near its 52-week low of $11.92, and this guidance cut extends the pressure seen in Q2, when net income already fell 36% on FX losses. Balance sheet remains a cushion: $89.4 million in cash and zero debt. Conference call today at 5:00 p.m. ET.
At the time of this announcement, NATR was trading at $11.55 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $225.9M. The 52-week trading range was $11.92 to $28.14. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.